Connect with us

Business

Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug – CNBC

A third member of a key FDA panel has resigned over the agency’s controversial decision to approve Biogen’s new Alzheimer’s drug,…

Published

on

Article feature image
ADVERTISEMENT

A third member of a key Food and Drug Administration advisory panel has resigned over the agency’s controversial decision to approve Biogen’s new Alzheimer’s drug, Aduhelm, CNBC has learned.
Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Toshiba’s No.2 shareholder calls for immediate resignation of board chair, 3 directors – Fox Business
Article feature image
Child found at Aurora Golden Corral, police looking for family – FOX 31 Denver
Hush-hush military satellite ready to ride Pegasus rocket into orbit – Spaceflight Now – Spaceflight Now